Clinical Trial Update: Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes the use of camrelizumab plus famitinib in advanced or metastatic pulmonary sarcomatoid carcinoma, with the study curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcomatoid Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)
• Famitinib (Famitinib)

Snippet

Sponsor: Qian Chu | Conditions: Sarcomatoid Carcinoma of Lung | Phase 2 | Status: RECRUITING